SCHEMBL31182653

SCHEMBL31182653

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O

nearest known ligand 0.62

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 12/20 0.62
▸ VIPR2 P41587 5/20 0.57
▸ BACE2 Q9Y5Z0 2/20 0.56
▸ VIPR1 P32241 4/20 0.55
▸ CTSD P07339 1/20 0.55
▸ PTH1R Q03431 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29438037 0.92 BACE1 (0.60) BACE1VIPR2BACE2VIPR1
SCHEMBL29461536 0.91 BACE1 (0.62) BACE1VIPR2VIPR1PTH1R
SCHEMBL30903279 0.91 BACE1 (0.62) BACE1VIPR2VIPR1
SCHEMBL29394956 0.90 BACE1 (0.58) BACE1VIPR2BACE2VIPR1CTSD
SCHEMBL29965017 0.90 BACE1 (0.57) BACE1VIPR2VIPR1PTH1R
SCHEMBL38664588 0.89 BACE1 (0.68) BACE1VIPR2VIPR1
SCHEMBL31182868 0.89 VIPR2 (0.61) BACE1VIPR2VIPR1PTH1R
SCHEMBL30974316 0.89 VIPR1 (0.60) BACE1VIPR2BACE2VIPR1CTSD
SCHEMBL29867509 0.89 VIPR2 (0.64) BACE1VIPR2VIPR1PTH1R
SCHEMBL29547594 0.88 BACE1 (0.63) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240350475-A1 TRIGONELLINE MITIGATES CARDIOMYOPATHY CAUSED BY SARS-COV-2 SPIKE PROTEIN UNDER OBESITY UNIVERSITY OF SOUTH CAROLINA (US) 2024-10-24 — — US disclosed
Send feedback